Main menu

The WIPE assay for selection and elimination of HIV-1 provirus in vitro using latency-reversing agents


Persistence of HIV-1 latent reservoir cells during antiretroviral therapy (ART) is a major obstacle for curing HIV-1. Latency-reversing agents (LRAs) are under intensive development to reactivate and eradicate latently infected cells; however, there are a few useful models for evaluating LRA activity in vitro. Here, we established a chronically HIV-1-infected culture system harboring thousands of different HIV-1-infected cell clones with a wide distribution of HIV-1 provirus similar to that observed in vivo. A combination of an LRA and an anti-HIV-1 drug successfully inhibited viral re-emergence after drug discontinuation, demonstrating “experimental cure” in the in vitro model. We demonstrated that the epigenetic environment of the integrated provirus plays a role in determining drug susceptibility. Our widely distributed intact provirus elimination (WIPE) assay will be useful for optimizing therapeutics against HIV-1 latency and provides mechanistic insights into the selection of heterogeneous HIV-1-infected clones during drug treatment.

Authors: Kouki Matsuda, Saiful Islam, Kiyoto Tsuchiya, Benjy Jek Yang Tan, Shin-ichiro Hattori, Hiroo Katsuya, Paola Miyazato, Misaki Matsuo, Nicole S. Delino, Hiroyuki Gatanaga, Shinichi Oka, Kazuhisa Yoshimura, Shuzo Matsushita, Hiroaki Mitsuya, Yorifumi Satou, Kenji Maeda

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag